Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Jul 2024 · 1 min read
In brief
In brief
This systematic review examines mechanisms driving liver fibrosis in biliary atresia (BA) and proposes a new grading system for assessing disease severity. The authors highlight TGF-β1 signaling as the critical pathway and identify epithelial-mesenchymal transition as a key area requiring further investigation to improve prognostic accuracy and treatment guidance in pediatric BA patients.
- TGF-β1 signaling pathway is identified as the most critical mechanism driving liver fibrosis progression in biliary atresia patients.
- A novel grading system for BA liver fibrosis may improve prognostic assessment and guide treatment decisions more accurately than existing methods.
- Epithelial-mesenchymal transition (EMT) in BA remains controversial and requires further investigation to clarify its role in fibrosis.
- Systematic review of 58 studies identified 25 mechanism-focused and 5 assessment-focused articles on BA liver fibrosis from a single research team.
- Better understanding of fibrosis mechanisms in BA could lead to targeted therapies to slow disease progression post-Kasai procedure.
Written by the GCMD Library team from the article.
Abstract
Purpose
This study systematically reviewed our team’s research on the mechanism and assessment of liver fibrosis in BA, summarized our experience, and discussed the future development direction.
Methods
In this study, Pubmed and Wanfang databases were searched to collect the literature published by our team on the mechanisms of liver fibrosis in BA and the assessment of liver fibrosis in BA, and the above research results were systematically reviewed.
Results
A total of 58 articles were retrieved. Among the included articles, 25 articles related to the mechanism of liver fibrosis in BA, and five articles evaluated liver fibrosis in BA. This article introduces the key pathways and molecules of liver fibrosis in BA and proposes a new grading system for liver fibrosis in BA.
Conclusions
The new BA liver fibrosis grading method is expected to assess children’s conditions, guide treatment, and improve prognosis more accurately. In addition, we believe that the TGF-β1 signaling pathway is the most important in the study of liver fibrosis in BA, and at the same time, the study of EMT occurrence in BA should also be deepened to resolve the controversy on this issue.